Longitudinal Imaging of Liver Cancer Using MicroCT and Nanoparticle Contrast Agents in CRISPR/Cas9-Induced Liver Cancer Mouse Model.
Sang Bu AnKwangmo YangChang Won KimSi Ho ChoiEunji KimSung Dae KimJae Soo KohPublished in: Technology in cancer research & treatment (2021)
Micro-computed tomography with nanoparticle contrast is useful in evaluating the induction and characteristics of liver cancer, determining appropriate size of liver cancer for testing, and confirming therapeutic response.